Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Psychother Res. 2021 Jun 2;32(3):291–305. doi: 10.1080/10503307.2021.1933646

Table 2.

Frequency and duration of specific meditation-related adverse effects

MRAES-MBP Item Any Never Days to 1 week 1 week to 1 month 1 month to 1 year 1 year+
1 12.44 87.56 9.45 1.84 0.46 0.69
2 26.96 73.04 21.89 2.30 1.61 1.15
3 25.81 74.19 18.66 3.92 1.61 1.61
4 22.81 77.19 15.67 4.15 1.38 1.61
5 16.13 83.87 9.22 3.46 1.61 1.84
6 17.97 82.03 11.29 3.46 1.84 1.38
7 19.35 80.65 11.52 3.23 1.38 3.23
8 15.21 84.79 10.14 1.84 1.38 1.84
9 13.82 86.18 7.14 3.00 1.84 1.84
10 19.59 80.41 13.36 2.76 2.30 1.15
11 5.76 94.24 3.00 1.15 0.23 1.38

Note: MRAES-MBP = Meditation-Related Adverse Effects Scale – Mindfulness-Based Program (Britton et al., 2018). MRAES-MBP items assess trouble thinking clearly (Item 1), anxiety (Item 2), traumatic re-experiencing (Item 3), emotional sensitivity (Item 4), trouble enjoying things (Item 5), feeling distant or cut off from others (Item 6), difficulty sleeping (Item 7), experiencing headaches and/or body pain (Item 8), sensitive hearing (Item 9), feeling disconnected from everything (Item 10), and other (Item 11). Values represent percentage of sample. n = 434.